KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Deferred Taxes (2016 - 2025)

Historic Deferred Taxes for Biogen (BIIB) over the last 17 years, with Q4 2025 value amounting to $166.9 million.

  • Biogen's Deferred Taxes rose 38578.77% to $166.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $361.6 million, marking a year-over-year increase of 32871.6%. This contributed to the annual value of $361.6 million for FY2025, which is 32871.6% up from last year.
  • Biogen's Deferred Taxes amounted to $166.9 million in Q4 2025, which was up 38578.77% from $253.8 million recorded in Q3 2025.
  • Biogen's 5-year Deferred Taxes high stood at $323.3 million for Q4 2021, and its period low was -$607.8 million during Q2 2021.
  • In the last 5 years, Biogen's Deferred Taxes had a median value of -$39.9 million in 2022 and averaged -$34.9 million.
  • Per our database at Business Quant, Biogen's Deferred Taxes soared by 61399.05% in 2021 and then plummeted by 655000.0% in 2023.
  • Quarter analysis of 5 years shows Biogen's Deferred Taxes stood at $323.3 million in 2021, then tumbled by 108.91% to -$28.8 million in 2022, then soared by 349.65% to $71.9 million in 2023, then tumbled by 181.22% to -$58.4 million in 2024, then surged by 385.79% to $166.9 million in 2025.
  • Its Deferred Taxes was $166.9 million in Q4 2025, compared to $253.8 million in Q3 2025 and -$31.3 million in Q2 2025.